NASDAQ Equity Snapshot
AVBP Weekly Equity Report
ArriVent BioPharma, Inc. Common Stock
What the company does
ArriVent BioPharma, Inc. (AVBP) is a biopharmaceutical innovator focused on delivering groundbreaking therapies to address critical unmet medical needs in oncology and autoimmune disorders. The company boasts a robust pipeline of therapies, employing proprietary technologies backed by a strong scientific framework, which are designed to enhance patient outcomes considerably. By concentrating on high-growth sectors within the biopharma landscape, ArriVent positions itself as an attractive investment opportunity for institutional investors looking to engage in transformative healthcare solutions that hold the promise of significant market impact.
What the weekly tape is saying
AVBP closed the latest completed week at 30.54 USD. The 4-week return is 9.6% and the 12-week return is 38.7%. Trend Signal is active, Market Dynamics is 0.95. Setup signature: Balanced read with a 70/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 24.70 USD
- Vs Trend Line
- 23.6%
- Fair Value
- 22.65 USD
- Vs Fair Value
- 34.8%
- 52W High
- 33.62 USD
- 52W Low
- 16.10 USD
- Drawdown
- -9.2%
- Range Position
- 82.4%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 23 weeks
- 52W Active Weeks
- 23
- 52W Active Breadth
- 44.2%
- Sector Scope
- US Healthcare
- Sector Rank
- 493 of 1038
- Sector Percentile
- 52.6%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
US Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 0.8%
- Avg 4W
- 3.5%
- Trend Breadth
- 33.0%
- Positive MD
- 41.0%
US Biotechnology
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 4.9%
- Avg 4W
- 1.7%
- Trend Breadth
- 46.0%
- Positive RS
- 47.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.95
- 4W MD Change
- -30.3%
- Relative Strength
- 14.05
- 4W RS Change
- 153.8%
- Expectation
- Undecided
- Probability
- 52.61%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 2.1M
- 13W Average
- 2.4M
- 52W Average
- 2.0M
- Vs 13W
- 0.9x
- Vs 52W
- 1.0x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 7.7%
- 52W Volatility
- 6.8%
- Upside Weeks
- 26
- Downside Weeks
- 26
- Downside Breadth
- 50.0%
- Avg Gain / Loss
- 6.1% / -4.6%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- NASDAQ
- Country
- US
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
- Market Cap
- 1.4B
Opportunity signals
- Trend Signal is active with a 23-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Market Dynamics is positive on the latest completed week.
Risk signals
- No major top-level risk cluster is currently dominant.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 30.54 USD | 0.6% | 24.70 USD | 22.65 USD | 0.95 | 14.05 | 2.1M | On |
| 5 Jun 2026 | 30.35 USD | 0.3% | 24.37 USD | 22.59 USD | 0.96 | 15.84 | 4.3M | On |
| 29 May 2026 | 30.27 USD | 13.2% | 23.96 USD | 22.52 USD | 0.94 | 10.24 | 2.7M | On |
| 22 May 2026 | 26.73 USD | -4.1% | 23.58 USD | 22.46 USD | 1.05 | 0.16 | 2.2M | On |
| 15 May 2026 | 27.87 USD | -5.5% | 23.31 USD | 22.42 USD | 1.36 | 5.54 | 1.5M | On |
| 8 May 2026 | 29.50 USD | -1.6% | 23.03 USD | 22.38 USD | 1.57 | 11.46 | 1.7M | On |
| 1 May 2026 | 29.99 USD | -1.4% | 22.74 USD | 22.32 USD | 1.65 | 19.55 | 2.3M | On |
| 24 Apr 2026 | 30.42 USD | 2.6% | 22.40 USD | 22.25 USD | 1.51 | 23.18 | 2.8M | On |
| 17 Apr 2026 | 29.64 USD | 16.4% | 21.99 USD | 22.18 USD | 0.90 | 22.90 | 2.1M | On |
| 10 Apr 2026 | 25.46 USD | 2.3% | 21.59 USD | 22.12 USD | 0.41 | 12.37 | 2.6M | On |
| 2 Apr 2026 | 24.89 USD | 16.1% | 21.40 USD | 22.09 USD | 0.12 | 14.84 | 2.2M | On |
| 27 Mar 2026 | 21.43 USD | -2.7% | 21.24 USD | 22.06 USD | -0.01 | 3.00 | 1.8M | On |
| 20 Mar 2026 | 22.02 USD | -7.9% | 21.16 USD | 22.07 USD | 0.17 | 2.29 | 2.7M | On |
| 13 Mar 2026 | 23.90 USD | 2.0% | 21.10 USD | 22.07 USD | 0.28 | 8.67 | 3.6M | On |